Concepedia

Kresna Hartandi

KH

Statistics

Publications

4

Citations

324

H-Index

4

Active since

2004

Affiliations

Abbott Fund(Current)

Kresna Hartandi is an author at Abbott Fund specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2004–2007

4

Publications

4

Discovery of<i>N</i>-(4-(3-Amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor

Yujia Dai, Kresna Hartandi, Zhiqin Ji et al. · Journal of Medicinal Chemistry · 2007 · 180 citations · Full text

, , +20

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

Deepa Shankar, Junling Li, Paul Tapang et al. · Blood · 2007 · 84 citations · Full text

Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors

Yujia Dai, Kresna Hartandi, Niru B. Soni et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 36 citations · Full text

, , +6

Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists

Irini Akritopoulou‐Zanze, Jyoti Patel, Kresna Hartandi et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 24 citations · Full text

, , +3

1–4 of 4